Mitoxantrone and VP-16 in refractory acute myelogenous leukemia. | Haematol Blood Transfus;30: 339-42, 1987. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Mitoxantrone and VP-16 in refractory acute myelogenous leukemia.

Ho, A D; Lipp, T; Ehninger, G; Meyer, P; Freund, M; Illiger, H J; Körbling, M.

Haematol Blood Transfus ; 30: 339-42, 1987.

Article in En | MEDLINE | ID: mdl-3305205

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Leukemia, Myeloid, Acute/drug therapy; Clinical Trials as Topic; Drug Administration Schedule; Etoposide/administration & dosage; Female; Humans; Male; Middle Aged; Mitoxantrone/administration & dosage; Remission Induction

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols Limits: Female / Humans / Male / Middle aged Language: En Journal: Haematol Blood Transfus Journal subject: HEMATOLOGIA Year: 1987 Document type: Article Country of publication: Germany

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Antineoplastic Combined Chemotherapy Protocols Limits: Female / Humans / Male / Middle aged Language: En Journal: Haematol Blood Transfus Journal subject: HEMATOLOGIA Year: 1987 Document type: Article Country of publication: Germany